The Nomination Committee’s recommendations for the Board of Humana AB
Prior to the 2018 AGM, Humana’s Nomination Committee, representing approx. 59 percent of the votes in the Company, recommends to the Annual General Meeting in 2018, that the existing Board of Directors in Humana is to be re-elected without any changes in the composition of the Board.
Prior to the Annual General Meeting on May 16, 2018, the Nomination Committee of Humana AB recommends that the Board of Directors of Humana AB is to be re-elected without any changes to the composition of the Board. The Nomination Committee's decision is based on the significant changes that were implemented in the Board of Directors during the previous year and that existing Board work is developing satisfactorily. The Nomination Committee recommends the re-election of Per Båtelson, Helen Fasth Gillstedt, Per Granath, Kirsi Komi, Monica Lingegård, Lloyd Perry and Ulrika Östlund. The Nomination Committee recommends that Per Båtelson be re-elected as Chairman of the Board.
The Nomination Committee prior to the 2018 AGM comprises: Lloyd Perry, appointed by Argan Capital (through the company Air Syndication SCA), Chair of the Committee; Alexander Kopp, appointed by Incentive AS; Katarina Hammar, appointed by Nordea Funds Ltd; Sven-Erik Zachrisson, appointed by Zirkona AB and Per Båtelson, Humana’s Chairman of the Board. The Nomination Committee’s members represent shareholders of approx. 59 percent of the total votes in the Company.
The Committee’s full recommendations, including recommendations for the Chairman of the AGM, election of auditors, Directors’ fees and auditors’ fees, an explanatory statement, information about the recommended Board members will be available before the AGM on Humana’s website http://corporate.humana.se
The Annual General Meeting of Humana AB will be held on Wednesday, 16 May 2017 at 13.00 in Lindhagen Mat & Möten premises, auditorium Horn, at Lindhagensgatan 126, Kungsholmen in Stockholm. The registration commences at 12:30 CET.
This information is information that Humana AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 08:00 CET on January 22, 2018.
For more information, please contact:
Lloyd Perry, Chair of the Nomination Committee, +44 7971 876 310
Per Båtelson, Chairman of Humana, +46 70 595 57 00
Cecilia Lannebo, Head of IR, +46 72-220 82 77, cecilia.lannebo@humana.se